MET exon 14 deletion (METex14): finally, a frequent-enough actionable oncogenic driver mutation in non-small cell lung cancer to lead MET inhibitors out of “40 years of wilderness” and into a clear path of regulatory approval

Gardado en:
Detalles Bibliográficos
Publicado en:Transl Lung Cancer Res
Main Authors: Reungwetwattana, Thanyanan, Ou, Sai-Hong Ignatius
Formato: Artigo
Idioma:Inglês
Publicado: AME Publishing Company 2015
Assuntos:
Commentary
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4700217/
https://ncbi.nlm.nih.gov/pubmed/26798595
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2218-6751.2015.12.03
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares